Dr. Gururangan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1840 Gateway Dr
3rd Floor
San Mateo, CA 94404Phone+1 628-212-8103- Is this information wrong?
Summary
- I am board -certified in pediatric hematology-oncology and Neuro-oncology, practice pediatric neuro-oncology full-time, and deeply committed to finding the best treatment options for children with brain tumors. My clinical research involves developing novel therapies through a vigorous interaction with laboratory scientists to translate new discoveries from the lab to the clinic. I am also working to understand why certain treatments do not work and how to improve upon on treatment failures.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1996 - 1999
- University of TennesseeFellowship, Pediatric Hematology/Oncology, 1993 - 1994
- University of TennesseeResidency, Pediatrics, 1992 - 1993
- University of TennesseeFellowship, Pediatric Hematology/Oncology, 1991 - 1992
- Stanley Medical College SMCClass of 1981
- Loyola CollegeB.S., Chemistry, 1976
Certifications & Licensure
- CA State Medical License 2023 - 2025
- FL State Medical License 2015 - 2024
- LA State Medical License 2020 - 2022
- NC State Medical License 1999 - 2016
- TN State Medical License 1994 - 1998
- AR State Medical License 1993 - 1997
- AL State Medical License 1993 - 1994
- American Board of Pediatrics Pediatric Hematology-Oncology
- Royal College of Physicians, Edinburgh, ScotlandF.R.C.P (Edin)
- Royal College of Physicians, United KingdomM.R.C.P (U.K.)
- United College of Neurologic SpecialitiesNeuro-Oncology
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- America's Top Doctors for Cancer Castle Connolly, 2010-2012
- Shining Star Award Make-A-Wish, Eastern North Carolina Chapter, 2009, 2015
- Join now to see all
Clinical Trials
- Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Start of enrollment: 2003 Aug 01
- Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma Start of enrollment: 2006 Aug 01
- Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System Start of enrollment: 2009 Feb 25
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsNivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908.Dunkel, I., Doz, F., Foreman, N., Hargrave, D., Lassaletta, A., André, N., Hansford, J., Hassall, T., Eyrich, M., Gururangan, S., Bartels, U., Gajjar, A., Howell, L., ...> ;Neuro-Oncology. 2023 Aug 3
- 55 citationsSerial assessment of measurable residual disease in medulloblastoma liquid biopsies.Anthony P. Y. Liu, Kyle S. Smith, Rahul Kumar, Leena Paul, Laure Bihannic, Tong Lin, Kendra K. Maass, Kristian W. Pajtler, Murali Chintagumpala, Jack Su, Eric Bouffet,...> ;Cancer Cell. 2021 Nov 8
- 7 citationsAccuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry.Margot A Lazow, Christine E. Fuller, Mariko DeWire, Adam Lane, Pratiti Bandopadhayay, Ute Bartels, Eric Bouffet, Sylvia Cheng, Kenneth J. Cohen, Tabitha Cooney, Scott ...> ;Neuro-Oncology. 2021 Oct 20
- Join now to see all
Journal Articles
- Heterogeneity Within the PF-EPN-B Ependymoma SubgroupAndrew Grossbach, Vijay Ramaswamy, Benjamin Lu, Mariarita Santi, Caterina Giannini, Linda M Liau, Terri S Armstrong, Sarah Leary, Matthias A Karajannis, Kenneth Aldape..., Acta Neuropathologica
- Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validationHan K, Peyret T, Quartino A, Gosselin NH, Gururangan S, Casanova M, Merks JH, Massimino M, Grill J, Daw NC, Navid F, Jin J, Allison DE, Br J Clin Pharmacol, 1/1/2016
- Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium studyHoffman LM, Fouladi M, Olson J, Daryani VM, Stewart CF, Wetmore C, Kocak M, Onar-Thomas A, Wagner L, Gururangan S, Packer RJ, Blaney SM, Gajjar A, Kun LE, Boyett JM, G..., Childs Nerv Syst, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A prospective phase II study to determine the efficacy of GDC 0449 (Vismodegib) in adults with recurrent medulloblastoma (MB)- a pediatric brain tumor consortium study...Gajjar A, Gururangan S, Qaddoumi I, Packer R, Goldman S, Prados M, Desjardins A, Fouladi M, Takebe N, Li S, Ellison D, Curren T, Gilbertson R, Boyett J, Am Assoc Cancer Res, 1/1/2013
- Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average risk or high risk medulloblastoma.Gurney J G, Bass J K, Onar-Thomas Arzu, Huang J, Chintagumpala M, Bouffet E, Hassall T, Gururangan S, Heath J A, Kellie S, Cohn R, Fisher M J, Pai-Panandiker Atmaram, ..., Proc Am Soc Clinical Oncol, 1/1/2013
- Corcordance between the Chang and the International Society of Pediatrics Oncology (SIOP) ototoxcity grading scales in medulloblastoma patients treated with cisplatin.Bass J K, Huang J, Onar-Thomas A, Chang K W, Bhagat S P, Chintagumpala M, Bartels U, Gururangan S, Hassel T, Heath J, McCowage G, Cohn R J, Fisher M J, Robison G, Bron..., Proc Am Soc Clinical Oncol, 1/1/2013
- Join now to see all
Lectures
- Principles of Anti-Angiogenic Therapies in Brain Tumors1/1/2012
- Overview of Pediatric Brain TumorsMultiple Locations, 2001, 2002, 2003, 2005, 2007, 2012 - 1/1/2012
- Low Grade Gliomas in Children1/1/2011
- Join now to see all
Committees
- Member, Cancer Protocol Review Committee, Duke Cancer Institute 2013 - Present
- Member, Appointments & Promotions Committee, Duke University 2012 - Present
- Member, Data Safety Monitoring Board, St. Jude Children's Research Hospital 2012 - Present
- Vice-Chair, Safety Oversight Committee, Duke Cancer Institute 2004 - Present
- Principal Investigator, Steering Committee, Pediatric Brain Tumor Consortium 2004 - Present
Other Languages
- Tamil
Industry Relationships
- Consultant, Biomarin2014 - Present
- Consultant, Advanced Medical2010 - Present
- Consultant, Boeheringer-IngenheimDrug development2009 - 2011
- Consultant, Biologics, Inc.,
- Consultant, NovartisHelped with drug development
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: